COVID-19
Researchers Develop Broadly Protective COVID-19 Vaccine Against Sars-cov-2 and Related Coronaviruses
Research conducted at the University of Cambridge has led to the development of a vaccine that elicits broad humoral responses against SARS-CoV-1, SARS-CoV-2, WIV16, and RaTG13 in mice, rabbits, and guinea pigs. The vaccine, designed using a viral-genome-informed computational method, offers protection from the Delta variant of SARS-CoV-2 in mice